Gambuzza, Maria Elsa, Salmeri, Francesca Maria, Soraci, Luca et al. · CNS & neurological disorders drug targets · 2015 · DOI
This review examines how certain immune system sensors called Toll-like receptors (TLRs) may contribute to ME/CFS. These receptors sit on cells in the gut and detect bacteria and other microbes, triggering inflammation that may spread to the brain and cause fatigue and other symptoms. The researchers suggest that targeting these TLRs with new medications might help reduce inflammation and improve symptoms.
Understanding the mechanisms driving ME/CFS inflammation is critical for developing effective treatments. This review identifies TLRs as a potential therapeutic target, offering hope for new drug development strategies that could interrupt the inflammatory cascade and provide symptom relief for ME/CFS patients.
This review does not present new experimental data proving that TLR dysfunction causes ME/CFS—it synthesizes existing literature. It does not establish that TLR-targeting drugs will be effective in humans with ME/CFS, nor does it determine causation versus correlation in the gut microbiome-immune-neurological relationships it describes.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Gambuzza, Maria Elsa, Salmeri, Francesca Maria, Soraci, Luca, Soraci, Giulia, Sofo, Vincenza, Marino, Silvia, et al. (2015). The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?. CNS & neurological disorders drug targets. https://doi.org/10.2174/1871527314666150325235247
BibTeX
@article{mecfsatlas-gambuzza-2015-role-toll,
author = {Gambuzza, Maria Elsa and Salmeri, Francesca Maria and Soraci, Luca and Soraci, Giulia and Sofo, Vincenza and Marino, Silvia and Bramanti, Placido},
title = {The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?},
journal = {CNS & neurological disorders drug targets},
year = {2015},
doi = {10.2174/1871527314666150325235247},
note = {PubMed: 25808894},
url = {https://www.mecfsatlas.com/evidence/gambuzza-2015-role-toll},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-27. https://www.mecfsatlas.com/evidence/gambuzza-2015-role-toll
Contribute
Private, reviewed by a human. Not a public comment thread.